Livia Augustin | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Livia Augustin | Medicine and Dentistry | Best Researcher Award

National Cancer Institute Pascale Napoli | Italy

Author Profile

Scopus

Early Academic Pursuits 🎓

Dr. Livia Augustin embarked on her academic journey with a Bachelor of Science in Nutritional Sciences and Human Biology from the University of Toronto in 1995, complemented by a minor in Psychology. Her passion for understanding the interplay between diet and health led her to pursue a Master of Science in Nutritional Sciences at the same institution, where she investigated the effects of wheat bran on serum lipids and colonic health. Dr. Augustin's quest for deeper knowledge culminated in a Doctor of Philosophy in Human Health and Nutritional Sciences from the University of Guelph in 2010. Her thesis explored the dietary glycemic index's implications on cancer risk, growth factors, and oxidative stress, marking a significant contribution to nutritional science.

Professional Endeavors 🌟

Dr. Augustin's professional career has been distinguished by her roles as a Nutrition Researcher and Study Coordinator at the National Cancer Institute Fondazione G. Pascale in Naples, Italy, since 2015. Her work has spanned across various esteemed institutions, including the Centro Riferimento Oncologico, Clinical Nutrition and Risk Factor Modification Centre at St. Michael’s Hospital, and the University of Milan. Her international collaborations extend to King's College London, Brighton University, and the Hellenic Health Foundation. Previously, she has worked at Unilever R&D, the Clinical Nutrition and Risk Factor Modification Centre, and as a Research Assistant at the Department of Epidemiology and the University of Toronto.

Contributions and Research Focus 🔬

Dr. Augustin's research has significantly advanced the understanding of lifestyle factors and their impact on cancer. Her notable studies include evaluating the long-term effects of integrated lifestyle treatments on breast cancer survivors and examining the influence of diet, exercise, and vitamin D supplementation on breast cancer recurrence. Her research has explored dietary habits, physical activity, and psychological states in breast cancer survivors, contributing valuable insights into improving quality of life and health outcomes in this population.

Accolades and Recognition 🏆

Dr. Augustin's contributions to nutritional science and cancer research have been recognized through several substantial grants. She has led projects funded by the Italian Ministry of Health and various Italian cancer research organizations, including LILT and the Lega Italiana per la Lotta contro i Tumori. Her grants support significant research into dietary interventions, cancer prevention, and quality of life improvements for cancer patients.

Impact and Influence 🌍

Dr. Augustin's work has had a profound impact on the field of nutrition and cancer research, influencing dietary recommendations and lifestyle interventions aimed at reducing cancer risk and improving patient outcomes. Her leadership in organizing scientific events and her role as a university speaker have further cemented her position as a leading figure in her field.

Legacy and Future Contributions 🌱

Looking ahead, Dr. Augustin continues to shape the future of nutritional science through her innovative research and commitment to improving cancer care. Her ongoing projects and collaborations promise to further advance our understanding of diet and lifestyle's role in health and disease. Her dedication to research supervision and student training also ensures that the next generation of scientists will benefit from her expertise and passion.

 

Publications 📘

  • 📄Baseline Association between Healthy Eating Index-2015 and Health-Related Quality of Life in Breast Cancer Patients Enrolled in a Randomized Trial
    Authors: Porciello, G., Coluccia, S., Vitale, S., Celentano, E., Augustin, L.S.A.
    Journal: Cancers
    Year: 2024
  • 📄Diabetes Risk Reduction Diet and Colorectal Cancer Risk
    Authors: Natale, A., Turati, F., Taborelli, M., Rossi, M., Vecchia, C.L.
    Journal: Cancer Epidemiology Biomarkers and Prevention
    Year: 2024
  • 📄Central Obesity, Body Mass Index, Metabolic Syndrome and Mortality in Mediterranean Breast Cancer Patients
    Authors: Crispo, A., Augustin, L.S.A., Luongo, A., La Vecchia, C., Arpino, G.
    Journal: Scientific Reports
    Year: 2023
  • 📄Diabetes Risk Reduction Diet and Ovarian Cancer Risk: An Italian Case-Control Study
    Authors: Esposito, G., Turati, F., Parazzini, F., Negri, E., La Vecchia, C.
    Journal: Cancer Causes and Control
    Year: 2023
  • 📄One-Year Nutrition Counselling in the Context of a Mediterranean Diet Reduced the Dietary Inflammatory Index in Women with Breast Cancer: A Role for the Dietary Glycemic Index
    Authors: Vitale, S., Palumbo, E., Polesel, J., Jenkins, D.J.A., Augustin, L.S.A.
    Journal: Food and Function
    Year: 2023

 

Feifei Feng | Health Professions | Best Researcher Award

Published on by Book of Award

Dr. Feifei Feng | Health Professions | Best Researcher Award 

The Second Hospital of Shandong University | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Feifei Feng embarked on her academic journey in clinical medicine, obtaining a Master's degree through a seven-year program at Zhejiang University (2005-2012). She continued her education with a Doctor of Medicine (MD) degree in Internal Medicine from Qilu Medical College, Shandong University (2017-2020). Her academic training laid a robust foundation in both clinical and research aspects of internal medicine, particularly focusing on respiratory and critical care.

Professional Endeavors

Dr. Feng's professional career has been marked by her role as an Associate Chief Physician in the Department of Respiratory and Critical Care Medicine at the Second Hospital of Shandong University (09/2022 - Present). In this capacity, she is responsible for the daily consultation and treatment of patients with respiratory and critical care needs. Her work emphasizes the diagnosis and management of respiratory diseases, with a particular focus on lung cancer and pulmonary fibrosis.

Contributions and Research Focus

Dr. Feng's research has significantly contributed to understanding and treating respiratory diseases. Her research focus includes:

*Silicosis and Pulmonary Fibrosis: Dr. Feng has extensively studied the pathogenesis of silicosis and the therapeutic effects of compounds like Tanshinone IIA in attenuating silica-induced pulmonary fibrosis.

*Cancer Therapy: Her work on the inhibitory effects of polyphyllins and their role in enhancing chemosensitivity of cancer cells to treatments like cisplatin has been groundbreaking.

*Signaling Pathways: She has delved into the molecular mechanisms underlying disease processes, such as the TGF-β1/Smad signaling pathway, EMT, NOX4 inhibition, and Nrf2/ARE signaling activation.

Accolades and Recognition

Dr. Feng's contributions to the field have been widely recognized through numerous publications in high-impact journals. Some of her notable works include:

"Role of TRIM59 in regulating PPM1A in the pathogenesis of silicosis and the intervention effect of tanshinone IIA" (Biomed Pharmacother, 2024).

"Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling" (Chem Biol Interact, 2020).

Impact and Influence

Dr. Feng's research has had a profound impact on the medical community's understanding of respiratory diseases and their treatment. Her studies on the molecular pathways involved in pulmonary fibrosis and cancer therapy have opened new avenues for developing targeted treatments. By elucidating the mechanisms of disease and identifying potential therapeutic agents, her work has contributed to improved patient outcomes and advanced the field of respiratory medicine.

Legacy and Future Contributions

Dr. Feng continues to make strides in her field through her ongoing clinical practice and research. Her dedication to understanding complex respiratory diseases and finding innovative treatments ensures that her contributions will have a lasting impact. Future research endeavors are likely to build on her current work, exploring new therapeutic targets and improving the quality of care for patients with respiratory diseases. Her legacy will be marked by her commitment to advancing medical science and improving patient health outcomes.

 

Notable Publications

Role of TRIM59 in regulating PPM1A in the pathogenesis of silicosis and the intervention effect of tanshinone IIA 2024

Inhibitory effects of polyphyllins I and VII on human cisplatin-resistant NSCLC via p53 upregulation and CIP2A/AKT/mTOR signaling axis inhibition 2019 (26)

Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling 2020 (52)

Polyphyllin I induces apoptosis and autophagy in temozolomide-resistant glioma via modulation of NRF2 and MAPK-signaling activation 2023 (2)

Ginsenoside Rb1 Alleviates Bleomycin-Induced Pulmonary Inflammation and Fibrosis by Suppressing Central Nucleotide-Binding Oligomerization-, Leucine-Rich Repeat-, and Pyrin Domains-Containing Protein Three Inflammasome Activation and the NF-κB Pathway 2022 (8)

Detection and significance of exosomal mRNA expression profiles in the cerebrospinal fluid of patients with meningeal carcinomatosis 2021 (6)

Astragaloside IV alleviates silica‑induced pulmonary fibrosis via inactivation of the TGF‑β1/Smad2/3 signaling pathway 2021 (23)

 

 

 

 

Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Mr. Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Hebrew University of Jerusalem | Israel

Author Profile

Orcid

Early Academic Pursuits

Mr. Jairus Nandwa's academic journey commenced with a Bachelor's in Industrial Microbiology and Biotechnology from The Technical University of Mombasa, Kenya. He pursued his passion further with a Master's in Biosciences from COMSATS University Islamabad, Pakistan, where he delved into cancer genetics. Currently, he is pursuing a Ph.D. in Genetics at The Hebrew University of Jerusalem, focusing on circular RNAs, SNORDs, and miRNAs in cancer under the guidance of Professor Ruth Sperling.

Professional Endeavors

Jairus has garnered diverse professional experiences, from his tenure as a Laboratory Analyst at the Regional Veterinary Investigation Laboratory, Kenya, to his role as the Head of Public Needs Research at the Integrated Cancer Research Foundation of Kenya. He has contributed significantly to cancer education and research, both as a volunteer and in leadership positions, demonstrating his commitment to advancing cancer management in Kenya.

Contributions and Research Focus

With a strong background in biochemistry, genetics, and molecular biology, Jairus has dedicated his research efforts to elucidating the roles of non-coding RNAs in gene expression regulation, tumor microenvironment, biomarker discovery, and DNA repair mechanisms. His research spans both experimental and computational domains, aiming to unravel the complexities of cancer genetics and improve therapeutic strategies.

Accolades and Recognition

Jairus's contributions to the field of cancer genetics have been recognized internationally. He has been awarded prestigious scholarships, including the Queen Elizabeth Commonwealth Scholarship, and has received honors for his academic achievements. Additionally, his research publications in reputable journals underscore his growing influence in the scientific community.

Impact and Influence

Through his research, leadership roles, and volunteer activities, Jairus has made a significant impact on cancer education, awareness, and research in Kenya. His work has contributed to the understanding of cancer pathogenesis and has paved the way for innovative approaches to cancer management and treatment.

Legacy and Future Contributions

As Jairus continues his doctoral studies and pursues his research interests in cancer genetics, he aims to leave a lasting legacy in the field through groundbreaking discoveries and transformative contributions. His multidisciplinary approach, coupled with his passion for scientific inquiry, positions him as a promising leader in cancer research with the potential to drive positive change in the global fight against cancer.

Notable Publications

miR-4716–3p and the target AKT2 Gene/rs2304186 SNP are associated with blood cancer pathogenesis in Pakistani population 2024

In silico analysis of RPS4X (X-linked ribosomal protein) with active components from black seed (Nigella sativa) for potential treatment of multiple sclerosis 2024

Therapeutic capability of selected medicinal plants' bioactive constituents against the mutant ovarian TP53 gene; a computational approach 2023

Targeting allosteric sites on PDK-1 and PLK-1 with bioactive compounds from Daucus carota as a potential therapy for triple-negative breast cancer 2023

 

 

 

 

Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Mr. Jairus Nandwa | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Hebrew University of Jerusalem | Israel

Author Profile

Scopus

Orcid

Early Academic Pursuits

Mr. Jairus Nandwa embarked on his academic journey with a Bachelor of Technology in Industrial Microbiology and Biotechnology from The Technical University of Mombasa, Kenya. He further pursued a Master of Science in Biosciences at COMSATS University Islamabad, Pakistan, and is currently pursuing a PhD in Genetics at The Hebrew University of Jerusalem, focusing on circular RNAs, SNORDS, and miRNAs in cancer under the guidance of Professor Ruth Sperling.

Professional Endeavors

With a robust academic background, Mr. Nandwa engaged in various research experiences, including his role as a Graduate Student/Research Student at the Cancer Genetics and Epigenetics Lab, COMSATS University, Pakistan. He also served as a Laboratory Analyst during his BTech internship at the Regional Veterinary Investigation Laboratory, Kenya.

Contributions and Research Focus

Mr. Nandwa's research interests span non-coding RNAs in gene expression regulation, tumor microenvironment, biomarker/therapeutic discovery, DNA repair mechanisms, and biological data analysis. He has authored several publications and presented his research at esteemed conferences globally.

Accolades and Recognition

His notable publications include research on miRNA-4716–3p and its association with blood cancer pathogenesis, earning recognition in Non-Coding RNA Research. He has also received awards such as the Queen Elizabeth Commonwealth Scholarship and First Class Honors in BTech Industrial Microbiology and Biotechnology.

Impact and Influence

Mr. Nandwa's contributions extend beyond academia, with leadership roles in cancer education initiatives and community service engagements. His research and volunteer efforts demonstrate a commitment to advancing scientific knowledge and addressing societal challenges.

Legacy and Future Contributions

As Mr. Nandwa continues his doctoral studies and research pursuits, his dedication to understanding the intricacies of cancer biology and contributing to innovative solutions positions him as a promising researcher in the field of genetics. His leadership, academic achievements, and community impact foreshadow a legacy of scientific excellence and social responsibility.

Notable Publications

miR-4716–3p and the target AKT2 Gene/rs2304186 SNP are associated with blood cancer pathogenesis in Pakistani population 2024

In silico analysis of RPS4X (X-linked ribosomal protein) with active components from black seed (Nigella sativa) for potential treatment of multiple sclerosis 2024

Therapeutic capability of selected medicinal plants' bioactive constituents against the mutant ovarian TP53 gene; a computational approach 2023

Targeting allosteric sites on PDK-1 and PLK-1 with bioactive compounds from Daucus carota as a potential therapy for triple-negative breast cancer 2023